| Authors: |
Jaeckel LF; Division of Translational Psychiatry, Department of Psychiatry (UPK) and Department of Clinical Research, University of Basel, Wilhelm Klein-Strasse 27, 4002 Basel, Switzerland., Logvinski D; Division of Translational Psychiatry, Department of Psychiatry (UPK) and Department of Clinical Research, University of Basel, Wilhelm Klein-Strasse 27, 4002 Basel, Switzerland., Kanana M; Division of Translational Psychiatry, Department of Psychiatry (UPK) and Department of Clinical Research, University of Basel, Wilhelm Klein-Strasse 27, 4002 Basel, Switzerland., Müller F; Clinical Research Unit for Substance-Based Therapy, Department of Psychiatry (UPK), University of Basel, Wilhelm Klein-Strasse 27, 4002 Basel, Switzerland.; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel and University of Basel, Schanzenstrasse 55, 4031 Basel, Switzerland., Rohner N; Division of Translational Psychiatry, Department of Psychiatry (UPK) and Department of Clinical Research, University of Basel, Wilhelm Klein-Strasse 27, 4002 Basel, Switzerland., Becker AM; Clinical Research Unit for Substance-Based Therapy, Department of Psychiatry (UPK), University of Basel, Wilhelm Klein-Strasse 27, 4002 Basel, Switzerland.; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel and University of Basel, Schanzenstrasse 55, 4031 Basel, Switzerland., Liechti ME; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel and University of Basel, Schanzenstrasse 55, 4031 Basel, Switzerland., Sterzer P; Division of Translational Psychiatry, Department of Psychiatry (UPK) and Department of Clinical Research, University of Basel, Wilhelm Klein-Strasse 27, 4002 Basel, Switzerland. |